Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1997 1
2000 1
2008 2
2011 4
2012 3
2013 1
2014 1
2015 3
2016 4
2017 3
2018 2
2019 2
2020 3
2021 1
2022 7
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Common and rare variant associations with clonal haematopoiesis phenotypes.
Kessler MD, Damask A, O'Keeffe S, Banerjee N, Li D, Watanabe K, Marketta A, Van Meter M, Semrau S, Horowitz J, Tang J, Kosmicki JA, Rajagopal VM, Zou Y, Houvras Y, Ghosh A, Gillies C, Mbatchou J, White RR, Verweij N, Bovijn J, Parikshak NN, LeBlanc MG, Jones M; Regeneron Genetics Center; GHS-RGC DiscovEHR Collaboration; Glass DJ, Lotta LA, Cantor MN, Atwal GS, Locke AE, Ferreira MAR, Deering R, Paulding C, Shuldiner AR, Thurston G, Ferrando AA, Salerno W, Reid JG, Overton JD, Marchini J, Kang HM, Baras A, Abecasis GR, Jorgenson E. Kessler MD, et al. Among authors: houvras y. Nature. 2022 Dec;612(7939):301-309. doi: 10.1038/s41586-022-05448-9. Epub 2022 Nov 30. Nature. 2022. PMID: 36450978 Free PMC article.
Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial.
Griesinger F, Curigliano G, Thomas M, Subbiah V, Baik CS, Tan DSW, Lee DH, Misch D, Garralda E, Kim DW, van der Wekken AJ, Gainor JF, Paz-Ares L, Liu SV, Kalemkerian GP, Houvras Y, Bowles DW, Mansfield AS, Lin JJ, Smoljanovic V, Rahman A, Kong S, Zalutskaya A, Louie-Gao M, Boral AL, Mazières J. Griesinger F, et al. Among authors: houvras y. Ann Oncol. 2022 Nov;33(11):1168-1178. doi: 10.1016/j.annonc.2022.08.002. Epub 2022 Aug 13. Ann Oncol. 2022. PMID: 35973665 Free article. Clinical Trial.
Oxidative Phosphorylation Promotes Primary Melanoma Invasion.
Salhi A, Jordan AC, Bochaca II, Izsak A, Darvishian F, Houvras Y, Giles KM, Osman I. Salhi A, et al. Among authors: houvras y. Am J Pathol. 2020 May;190(5):1108-1117. doi: 10.1016/j.ajpath.2020.01.012. Epub 2020 Mar 3. Am J Pathol. 2020. PMID: 32142731 Free PMC article.
Melanoma biology and the promise of zebrafish.
Ceol CJ, Houvras Y, White RM, Zon LI. Ceol CJ, et al. Among authors: houvras y. Zebrafish. 2008 Dec;5(4):247-55. doi: 10.1089/zeb.2008.0544. Zebrafish. 2008. PMID: 19133823 Free PMC article. Review.
Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.
Neelamraju Y, Gjini E, Chhangawala S, Fan H, He S, Jing CB, Nguyen AT, Prajapati S, Sheridan C, Houvras Y, Melnick A, Look AT, Garrett-Bakelman FE. Neelamraju Y, et al. Among authors: houvras y. Front Hematol. 2023;2:1235170. doi: 10.3389/frhem.2023.1235170. Epub 2023 Sep 14. Front Hematol. 2023. PMID: 37937078 Free PMC article.
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.
Raman R, Villefranc JA, Ullmann TM, Thiesmeyer J, Anelli V, Yao J, Hurley JR, Pauli C, Bareja R, Wha Eng K, Dorsaint P, Wilkes DC, Beg S, Kudman S, Shaw R, Churchill M, Ahmed A, Keefer L, Misner I, Nichol D, Gumpeni N, Scognamiglio T, Rubin MA, Grandori C, Solomon JP, Song W, Mosquera JM, Dephoure N, Sboner A, Elemento O, Houvras Y. Raman R, et al. Among authors: houvras y. J Exp Med. 2022 Jun 6;219(6):e20210390. doi: 10.1084/jem.20210390. Epub 2022 May 5. J Exp Med. 2022. PMID: 35510953 Free PMC article.
Histone 3 Methyltransferases Alter Melanoma Initiation and Progression Through Discrete Mechanisms.
DiNapoli SE, Martinez-McFaline R, Shen H, Doane AS, Perez AR, Verma A, Simon A, Nelson I, Balgobin CA, Bourque CT, Yao J, Raman R, Béguelin W, Zippin JH, Elemento O, Melnick AM, Houvras Y. DiNapoli SE, et al. Among authors: houvras y. Front Cell Dev Biol. 2022 Feb 10;10:814216. doi: 10.3389/fcell.2022.814216. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35223844 Free PMC article.
39 results